CVS CVS HEALTH Corp

  1. Stocks
  2. Healthcare
  3. NYSE: CVS

Price (delayed)

$100.68

Market cap

$128.46B

P/E Ratio

43.4

Dividend/share

$2.66

EPS

$2.32

Enterprise value

$197.26B

?
Relative Growth: Rel. Growth: 40
Relative Strength: Rel. Strength: 78
Relative Valuation: Rel. Valuation: 51
Relative Profitability: Rel. Profitability: 31

CVS Health is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. ...

Highlights
The revenue has grown by 8% YoY
CVS's quick ratio is up by 7% QoQ and by 3.4% YoY
The net income has surged by 66% since the previous quarter but it has declined by 44% year-on-year
CVS HEALTH's EPS has surged by 66% QoQ but it has decreased by 45% YoY
Sector: Healthcare
Industry: Healthcare Plans
Website: https://cvshealth.com/
Peers: PETS WMT

Key stats

What are the main financial stats of CVS

CVS stock price

How has the CVS HEALTH stock price performed over time
Intraday
-1.26%
1 week
3.71%
1 month
5%
1 year
49.24%
YTD
26.86%
QTD
40.18%

Financial performance

How have CVS HEALTH's revenue and profit performed over time
Revenue
$407.91B
Gross profit
$56.59B
Operating income
$5.97B
Net income
$2.93B
Gross margin
13.9%
Net margin
0.7%
The net margin has soared by 75% from the previous quarter but it has plunged by 50% YoY
The net income has surged by 66% since the previous quarter but it has declined by 44% year-on-year
The company's operating margin fell by 40% YoY but it rose by 25% QoQ
The operating income has declined by 38% year-on-year but it is up by 28% since the previous quarter

Price vs fundamentals

How does CVS's price correlate with its fundamentals

Growth

What is CVS HEALTH's growth rate over time

Valuation

What is CVS HEALTH stock price valuation
CVS P/E details
P/E
43.4
P/B
1.65
P/S
0.31
EV/EBIT
29.92
EV/EBITDA
36.26
EV/Sales
0.48
CVS HEALTH's EPS has surged by 66% QoQ but it has decreased by 45% YoY
CVS's price to earnings (P/E) is 51% higher than its 5-year quarterly average of 29.2 but 40% lower than its last 4 quarters average of 73.8
CVS's price to book (P/B) is 39% more than its last 4 quarters average of 1.2 and 19% more than its 5-year quarterly average of 1.4
CVS's equity is up by 3% QoQ
The stock's price to sales (P/S) is 60% more than its last 4 quarters average of 0.2 and 7% more than its 5-year quarterly average of 0.3
The revenue has grown by 8% YoY

Efficiency

How efficient is CVS HEALTH business performance
CVS's ROE has soared by 70% QoQ but it is down by 44% YoY
The return on assets has surged by 57% since the previous quarter but it has declined by 48% year-on-year
CVS HEALTH's return on sales has decreased by 41% YoY but it has increased by 23% QoQ
CVS HEALTH's return on invested capital has decreased by 35% YoY but it has increased by 23% QoQ

Dividends

What is CVS's dividend history
Dividend details
DPS
$2.66
Dividend yield
2.64%
Payout ratio
114.7%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did CVS HEALTH financials performed over time
CVS HEALTH's total assets is 44% more than its total liabilities
CVS's quick ratio is up by 7% QoQ and by 3.4% YoY
The current ratio has grown by 6% year-on-year and by 3.6% since the previous quarter
CVS HEALTH's debt to equity has decreased by 4.7% QoQ and by 4.7% YoY
The debt has contracted by 3.5% YoY and by 2% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.